1. Home
  2. MTEK vs NCNA Comparison

MTEK vs NCNA Comparison

Compare MTEK & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maris-Tech Ltd.

MTEK

Maris-Tech Ltd.

HOLD

Current Price

$0.42

Market Cap

4.1M

Sector

N/A

ML Signal

HOLD

Logo NuCana plc

NCNA

NuCana plc

BUY

Current Price

$0.99

Market Cap

4.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MTEK
NCNA
Founded
2008
1997
Country
Israel
United Kingdom
Employees
16
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
4.0M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
MTEK
NCNA
Price
$0.42
$0.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 511.9K
73.9K
Earning Date
09-02-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.95
52 Week High
$2.82
$4.55

Technical Indicators

Market Signals
Indicator
MTEK
NCNA
Relative Strength Index (RSI) 26.16 34.43
Support Level N/A $0.95
Resistance Level $1.12 $1.40
Average True Range (ATR) 0.05 0.06
MACD -0.00 -0.00
Stochastic Oscillator 14.87 22.35

Price Performance

Historical Comparison
MTEK
NCNA

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a B2B provider of intelligent video transmission technology with AI acceleration for edge platforms, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures, and commercially sells miniature intelligent video and audio surveillance and communication systems with AI acceleration for the professional, civilian, and home security markets. Its products and solutions are sold as off-the-shelf, standalone, and ready-to-use products, or as customized components that meet customers' requirements and integrate into their systems and products. Its customers include companies operating in the drone, robotic, defense, HLS, intelligence gathering, autonomous vehicle, and space markets. It generates maximum revenue from Israel.

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

Share on Social Networks: